A comprehensive cardiovascular management system, Dynamo CV, promises to integrate clinical, financial, and cardiovascular data, allowing the comparison of patient treatment and outcomes among healthcare facilities. Dynamo CV, developed by GE Medical
A comprehensive cardiovascular management system, Dynamo CV, promises to integrate clinical, financial, and cardiovascular data, allowing the comparison of patient treatment and outcomes among healthcare facilities. Dynamo CV, developed by GE Medical Systems Information Technologies, addresses more than 200 clinical and financial data elements per patient encounter and more than 150 cardiovascular data elements. The system helps healthcare providers monitor and compare a range of parameters, including drug and blood product administration, preoperative diagnostic evaluations, and anatomic and physiologic findings obtained in cardiac cath labs.
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.
The Reading Room Podcast: A Closer Look at Remote MRI Safety, Part 2
July 25th 2025In the second of a multi-part podcast episode, Emanuel Kanal, M.D. and Tobias Gilk, MRSO, MRSE, share their perspectives on remote MRI safety protocols for ensuring screening accuracy and adherence to conditional implant guidelines as well as a rapid and effective response to adverse events.
The Reading Room Podcast: Current and Emerging Insights on Abbreviated Breast MRI, Part 2
July 23rd 2025In the second part of a multi-part podcast episode, Stamatia Destounis, MD, Emily Conant, MD and Habib Rahbar, MD, discuss key sequences for abbreviated breast MRI and how it stacks up to other breast cancer screening modalities.
Chest CT for Post-COVID-19 Abnormalities: Nine Takeaways from a Multi-Society Consensus Statement
July 22nd 2025Developed by 21 thoracic radiologists, the new international consensus statement addresses appropriate indications, scan acquisition and keys to reporting for the use of chest CT imaging in evaluating for residual lung abnormalities from COVID-19.